Evidence map›Paper›PMID 38798587›Full record

ArticlebioRxiv : the preprint server for biology2025

Caspase-11 drives macrophage hyperinflammation in models of Polg-related mitochondrial disease.

Jordyn J VanPortfliet, Yuanjiu Lei, Muthumeena Ramanathan, Camila Guerra Martinez, Jessica Wong, Tim J Stodola, Brian R Hoffmann, Kathryn Pflug, Raquel Sitcheran, Stephen C Kneeland and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Jordyn J VanPortflietThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Yuanjiu LeiDepartment of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M University, Bryan, Texas 77807, USA.
Muthumeena RamanathanThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Camila Guerra MartinezDepartment of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M University, Bryan, Texas 77807, USA.
Jessica WongThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Tim J StodolaThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Brian R HoffmannThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Kathryn PflugDepartment of Cell Biology and Genetics, College of Medicine, Texas A&M University, Bryan, Texas 77807, USA.
Raquel SitcheranDepartment of Cell Biology and Genetics, College of Medicine, Texas A&M University, Bryan, Texas 77807, USA.
Stephen C KneelandThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Stephen A MurrayThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Peter J McGuireMetabolism, Infection and Immunity Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, 20892, USA.ORCID 0000-0001-5601-3044
Carolyn L CannonDepartment of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M University, Bryan, Texas 77807, USA.
A Phillip WestThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0003-2884-6895

Funding

Metabolism, infection and immunity in inborn errors of mitochondrial metabolismZIAHG200381 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI MCGUIRE, PETER · 2012 to 2025
$21.7M
The Jackson Laboratory Center for Precision GeneticsU54OD030187 · OD · JACKSON LABORATORY · PI Cathleen M Lutz, Stephen A Murray · 2020 to 2026
$17.2M
Type I Interferon Responses in the Pathobiology of Anthracycline-induced CardiotoxicityR01HL148153 · NHLBI · TEXAS A&M UNIVERSITY · PI John Travis Hinson, Andrew Phillip West · 2020 to 2026
$2.8M
Targeting the Nrf2 axis to reduce lung immunopathology in PolG-related mitochondrial diseaseF31AI179168 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI VAN PORTFLIET, JORDYN · 2024 to 2025
$50k
NHLBI NIH HHS R01 HL148153NIAID NIH HHS F31 AI179168NIH HHS U54 OD030187
6 · The paper itself

Abstract

Mitochondrial diseases (MtD) represent a significant public health challenge due to their heterogenous clinical presentation, often severe and progressive symptoms, and lack of effective therapies. Environmental exposures, such bacterial and viral infection, can further compromise mitochondrial function and exacerbate the progression of MtD. Infections in MtD patients more frequently progress to sepsis, pneumonia, and other detrimental inflammatory endpoints. However, the underlying immune alterations that enhance immunopathology in MtD remain unclear, constituting a key gap in knowledge that complicates treatment and increases mortality in this vulnerable population. Here we employ in vitro and in vivo approaches to clarify the molecular and cellular basis for innate immune hyperactivity in models of polymerase gamma (Polg)-related MtD. We reveal that type I interferon (IFN-I)-mediated upregulation of caspase-11 and guanylate-binding proteins (GBPs) increase macrophage sensing of the opportunistic microbe

Identifiers

PMID38798587
PMCPMC11118447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.